# Neurocarrus

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neurocarrus

- Industry: Biotechnology
- Headquarters: San Francisco, US
- Website: www.neurocarrus.com
- Latest round: Seed (Oct 27, 2017)
- Investors on record: 2

## About

Founded in 2015 and based in California, US, Neurocarrus Inc. is a biotechnology company that develops novel therapy to treat pain without addiction-forming medications or disruption of muscular control. It uses protein engineering to develop a novel, non-opioid remedial that targets sensory neurons to stop pain wave before it gets to the brain. The company's N-001 therapeutic is designed to treat the physiological symptoms of pain without invasive surgical procedures or systemically absorbed drugs.

## Funding rounds

- Seed, Oct 27, 2017 — SOSV, IndieBio

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed
- IndieBio (https://capitalatlas.ai/funds/indiebio) — Seed